CA123541/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2006	2
2007	1
2008	2
2009	1
2010	4
2011	3
2012	1
2013	2
2014	2
2015	1
2016	2
2017	4
2018	2
2019	1
2024	0

1

MUC1 and MUC4: switching the emphasis from large to small.

Albrecht H, Carraway KL 3rd. Albrecht H, et al. Cancer Biother Radiopharm. 2011 Jun;26(3):261-71. doi: 10.1089/cbr.2011.1017. Cancer Biother Radiopharm. 2011. PMID: 21728842 Free PMC article. Review.

2

Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.

Saldana M, VanderVorst K, Berg AL, Lee H, Carraway KL. Saldana M, et al. Endocr Relat Cancer. 2019 Jan 1;26(1):R1-R14. doi: 10.1530/ERC-18-0264. Endocr Relat Cancer. 2019. PMID: 30400005 Free PMC article. Review.

3

Cellular and molecular mechanisms underlying planar cell polarity pathway contributions to cancer malignancy.

VanderVorst K, Hatakeyama J, Berg A, Lee H, Carraway KL 3rd. VanderVorst K, et al. Semin Cell Dev Biol. 2018 Sep;81:78-87. doi: 10.1016/j.semcdb.2017.09.026. Epub 2017 Nov 4. Semin Cell Dev Biol. 2018. PMID: 29107170 Free PMC article. Review.

4

Vangl1 and Vangl2: planar cell polarity components with a developing role in cancer.

Hatakeyama J, Wald JH, Printsev I, Ho HY, Carraway KL 3rd. Hatakeyama J, et al. Endocr Relat Cancer. 2014 Oct;21(5):R345-56. doi: 10.1530/ERC-14-0141. Epub 2014 Jun 30. Endocr Relat Cancer. 2014. PMID: 24981109 Free PMC article. Review.

5

Membrane Protein Quantity Control at the Endoplasmic Reticulum.

Printsev I, Curiel D, Carraway KL 3rd. Printsev I, et al. J Membr Biol. 2017 Aug;250(4):379-392. doi: 10.1007/s00232-016-9931-0. Epub 2016 Oct 14. J Membr Biol. 2017. PMID: 27743014 Free PMC article. Review.

6

E3 ubiquitin ligases in ErbB receptor quantity control.

Carraway KL 3rd. Carraway KL 3rd. Semin Cell Dev Biol. 2010 Dec;21(9):936-43. doi: 10.1016/j.semcdb.2010.09.006. Epub 2010 Sep 22. Semin Cell Dev Biol. 2010. PMID: 20868762 Free PMC article. Review.

7

Mechanisms of ErbB receptor negative regulation and relevance in cancer.

Fry WH, Kotelawala L, Sweeney C, Carraway KL 3rd. Fry WH, et al. Exp Cell Res. 2009 Feb 15;315(4):697-706. doi: 10.1016/j.yexcr.2008.07.022. Epub 2008 Jul 31. Exp Cell Res. 2009. PMID: 18706412 Free PMC article. Review.

8

Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.

Yen L, Cao Z, Wu X, Ingalla ER, Baron C, Young LJ, Gregg JP, Cardiff RD, Borowsky AD, Sweeney C, Carraway KL 3rd. Yen L, et al. Cancer Res. 2006 Dec 1;66(23):11279-86. doi: 10.1158/0008-5472.CAN-06-2319. Cancer Res. 2006. PMID: 17145873

9

Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination.

Wald JH, Hatakeyama J, Printsev I, Cuevas A, Fry WHD, Saldana MJ, VanderVorst K, Rowson-Hodel A, Angelastro JM, Sweeney C, Carraway KL Rd. Wald JH, et al. Oncogene. 2017 Sep 7;36(36):5158-5167. doi: 10.1038/onc.2017.126. Epub 2017 May 8. Oncogene. 2017. PMID: 28481871 Free PMC article.

10

The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3.

Hatakeyama J, Wald JH, Rafidi H, Cuevas A, Sweeney C, Carraway KL 3rd. Hatakeyama J, et al. Sci Signal. 2016 Jun 28;9(434):ra65. doi: 10.1126/scisignal.aaf1604. Sci Signal. 2016. PMID: 27353365 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year